Clinical trial of subsequent injection of HVJ-E to those patients who enrolled in the clinical trial of 'Phase I/II clinical trial to assess safety and efficacy of intratumoural and subcutaneous injection of HVJ-E to castration resistant prostate cancer patients' [EXTENSION OF 700205839]

Trial Profile

Clinical trial of subsequent injection of HVJ-E to those patients who enrolled in the clinical trial of 'Phase I/II clinical trial to assess safety and efficacy of intratumoural and subcutaneous injection of HVJ-E to castration resistant prostate cancer patients' [EXTENSION OF 700205839]

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 22 Jun 2013

At a glance

  • Drugs GEN 0101 (Primary)
  • Indications Prostate cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 22 Jun 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top